ARTAC, M. Et Al. 2014. Complete response and long-term remission to anti-HER2 combined therapy in a patient with breast cancer presented with bone marrow metastases.. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners , vol.20 , 141-5.

ARTAC, M., Koral, L., TOY, H., GULER, T., BORUBAN, M., & ALTUNDAG, K., (2014). Complete response and long-term remission to anti-HER2 combined therapy in a patient with breast cancer presented with bone marrow metastases.. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners , vol.20, 141-5.

ARTAC, M Et Al. "Complete response and long-term remission to anti-HER2 combined therapy in a patient with breast cancer presented with bone marrow metastases.," Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners , vol.20, 141-5, 2014

ARTAC, M Et Al. "Complete response and long-term remission to anti-HER2 combined therapy in a patient with breast cancer presented with bone marrow metastases.." Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners , vol.20, pp.141-5, 2014

ARTAC, M. Et Al. (2014) . "Complete response and long-term remission to anti-HER2 combined therapy in a patient with breast cancer presented with bone marrow metastases.." Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners , vol.20, pp.141-5.

@article{article, author={M ARTAC Et Al. }, title={Complete response and long-term remission to anti-HER2 combined therapy in a patient with breast cancer presented with bone marrow metastases.}, journal={Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners}, year=2014, pages={141-5} }